[EN] DIHYDROINDOLIZINE DERIVATE AS METABOTROPIC GLUTAMATE RECEPTOR MODULATORS<br/>[FR] DÉRIVÉ DE DIHYDROINDOLIZINE À TITRE DE MODULATEURS DES RÉCEPTEURS MÉTABOTROPES DE GLUTAMATE
申请人:MERZ PHARMA GMBH & CO KGAA
公开号:WO2012172093A1
公开(公告)日:2012-12-20
The invention relates to heterocyclic derivatives of formula I, wherein the substituents R1-R5 and R11 are as defined in the claims, as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
该发明涉及式I的杂环衍生物,其中取代基R1-R5和R11如索权中定义的,以及它们的药学上可接受的盐。该发明还涉及一种制备这种化合物的方法。该发明的化合物是mGluR5调节剂,因此对控制和预防急性和/或慢性神经系统疾病有用。